Stock listing

ATOS Stock Price, News, Filings & Events — Atossa Therapeutics, Inc.

Selected listing: ATOS · BOATS · USD · US

This page tracks Atossa Therapeutics, Inc.'s ATOS:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ATOS:BOATS. ATOS:BOATS is the stock-level entry point for investors researching Atossa Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Atossa Therapeutics, Inc. is a public company traded under the ticker ATOS in the American market. The company has a market capitalization of approximately $22.89 million. Atossa focuses on developing innovative therapeutics for breast cancer and other breast-related diseases.

ATOS:BOATSUSDUSUpdated September 11, 2026
Atossa Therapeutics, Inc. logo
Ticker
ATOS:BOATS
Asset type
Stock
Market cap
$25.0M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Atossa Therapeutics, Inc. ATOS:BOATS stock context

This page tracks Atossa Therapeutics, Inc.'s ATOS:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ATOS:BOATS. ATOS:BOATS is the stock-level entry point for investors researching Atossa Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Atossa Therapeutics, Inc. is a public company traded under the ticker ATOS in the American market. The company has a market capitalization of approximately $22.89 million. Atossa focuses on developing innovative therapeutics for breast cancer and other breast-related diseases.

Latest news from Atossa Therapeutics, Inc.

All Atossa Therapeutics, Inc. news →

Atossa Therapeutics, Inc. earnings calls

Research Atossa Therapeutics, Inc.

Alternate listings